Desktop Site
|
29 Apr 24 | 15:59
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,671.28
+941.12
+1.28 %
Corporate Announcement
Security Code
512217
Company
Prism Medico and Pharmacy Ltd
Exchange Received Time
13/02/2024 16:20:15
Exchange Disseminated Time
13/02/2024 16:20:17
Time Taken
00:00:02
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015. |
2/13/2024 4:20:17 PM
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 13th February, 2024) which commenced at 03:00 P.M. and concluded at 04:00 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2023 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige. Thanking You.
Attachment
<< Back
Recently Viewed